HIF1A and breast cancer: By increasing the interaction between PHD2 and pVHL in tamoxifen-resistant breast cancer cells, glucose uptake, lactate production, ATP production, lactate/pyruvate ratio, and expression of HIF-1-targeted glycolytic genes are all reduced.